Opportunity
Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder
Response due
September 15, 2026
- Agency
- National Institutes of Health
- Estimated value
- Not stated
Key dates
- Posted
- September 8, 2026
- Response due
- September 15, 2026
Who is this buyer
Organization
Buying history
- Records29 total
- Opportunities / awards1 / 1
- ActiveJuly 21, 2026 – October 20, 2026
What they buy
- Clinical (26)
- Administrative (3)
Set-asides used
- No Set aside used (27)
Also open from this buyer
- Scientific Equipment Maintenance 2 ION Chef Sequencers (ION S5 XL and ION S5 Prime)Due October 28, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- No Set aside used
- NAICS
- 541380
- PSC
- Q301